Semliki Forest Virus-Mediated Production of Retroviral Vector RNA in Retroviral Packaging Cells
- 20 November 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (17) , 2031-2041
- https://doi.org/10.1089/hum.1997.8.17-2031
Abstract
Retroviral vectors are efficient tools for gene transfer studies. Their major advantage is that they can permanently integrate the transgene into the target cell's genome. However, because of the compulsory nuclear expression phase of their life cycle, it can be difficult for retroviruses to carry complex expression cassettes. In a attempt to mimic the structural features of most eukaryotic genes and obtain a potentially self-amplifying system for retrovirus production, we tested the feasibility of Semliki Forest virus (SFV) expression to mediate cytoplasmic synthesis of retrovirus vector RNA. An equivalent of a retrovirus virion RNA (retrovirus vector cassette, RVC) was cloned under the SFV 26S promoter, and full-length chimeric SFV-RVC RNA was produced in vitro. This RNA was introduced into retrovirus packaging cells, either via electroporation or transduction in SFV virions, and supernatants were analyzed for the presence of biologically active retroviruses. We demonstrate that this strategy can be used for cytoplasmic retrovirus production. The resulting viral particles are fully functional; they can transduce target cells, undergo reverse transcription, and integrate into genomic DNA. We also demonstrate that the SFV virion-based RVC delivery into packaging cells can yield high transient titers, in this case more than 105 G418R cfu/ml. This study shows that a simple, one-plasmid, heterologous viral RNA production system can be used to create functional retroviral RNA outside the cell nucleus. Wahlfors et al. report that retroviral vector RNA can be efficiently synthesized in the cytoplasm of retroviral vector packaging cell lines using an alphavirus-based expression system. This method liberates vector design from the constraints imposed by synthesis of RNA in the cell nucleus.Keywords
This publication has 24 references indexed in Scilit:
- A Simple and Reliable Method for Screening Retroviral Producer Clones Without Selectable MarkersHuman Gene Therapy, 1997
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Analysis oftrans-Dominant Mutants of the HIV Type 1 Rev Protein for Their Ability to Inhibit Rev Function, HIV Type 1 Replication, and Their Use as Anti-HIV Gene TherapeuticsAIDS Research and Human Retroviruses, 1995
- Use of Sodium Butyrate to Enhance Production of Retroviral Vectors Expressing CFTR cDNAHuman Gene Therapy, 1995
- Retrovirus-Mediated Transduction of an Engineered Intron-Containing Purine Nucleoside Phosphorylase GeneHuman Gene Therapy, 1995
- Spermine Gates Inward-rectifying Muscarinic but Not ATP-sensitive K+ Channels in Rabbit Atrial MyocytesPublished by Elsevier ,1995
- Sequences Within the Coding Regions of Clotting Factor VIII and CFTR Block Transcriptional ElongationHuman Gene Therapy, 1995
- Semliki Forest Virus Expression System: Production of Conditionally Infectious Recombinant ParticlesNature Biotechnology, 1993
- Sequences in the Coding Region of Clotting Factor VIII Act as Dominant Inhibitors of RNA Accumulation and Protein ProductionHuman Gene Therapy, 1993
- A New Generation of Animal Cell Expression Vectors Based on the Semliki Forest Virus RepliconBio/Technology, 1991